[Federal Register Volume 64, Number 166 (Friday, August 27, 1999)]
[Notices]
[Page 46954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22307]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances Notice of Registration
By Notice dated March 1, 1999, and published in the Federal
Register on April 9, 1999, (64 FR 17416), Lipomed, Inc., One Broadway,
Cambridge, Massachusetts 02142, made application to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic classes of controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methaqualone (2565)........................ I
Lysergic acid diethylamide (7315).......... I
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3, 4, 5-Trimethoxyamphetamine (7390)....... I
4-Bromo-2, 5-dimethoxyamphetamine (7391)... I
4-Methyl-2, 5-dimethoxyamphetamine (7395).. I
2, 5-Dimethoxyamphetamine (7396)........... I
2, 5-Dimethoxy-4-ethylamphetamine (7399)... I
3, 4-Methylenedioxyamphetamine (7400)...... I
3, 4-Methylenedioxy-N-ethylamphetamine I
(7404).
3, 4-Methylenedioxymethamphetamine (7405).. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Acetyldihydrocodeine (9051)................ I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Tilidine (9750)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Secobarbital (2315)........................ II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Methadone (9250)........................... II
Dextroproproxyphene, bulk (non-dosage II
forms) (9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Alfentanil (9737).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The firm plans to import small reference standard quantities of
finished commercial product from its sister company in Switzerland for
sale to its customers for drug testing and pharmaceutical research and
development.
No comments or objections have been received. DEA has considered
the factors of Title 21, United States Code, Section 823(a) and
determined that the registration of Lipomed, Inc. to import the listed
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Lipomed, Inc. on a regular basis to ensure that the company's continued
registration is consistent with the public interest. These
investigations have included inspection and testing of the company's
physical security systems, audits of the company's records,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore pursuant to
Section 1008(a) of the Controlled Substances Import and Export Act and
in accordance with Title 21, Code of Federal Regulations, Section
1311.42, the above firm is granted registration as an importer of the
basic classes of controlled substances listed above.
Dated: August 17, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administrator.
[FR Doc 99-22307 Filed 8-26-99; 8:45 am]
BILLING CODE 4410-09-M
